Variables | Overall | MetS | non-MetS | ||||||
---|---|---|---|---|---|---|---|---|---|
Poor collateralization n = 355 | Good collateralization n = 1298 | P value | Poor collateralization n = 222 | Good collateralization n = 640 | P value | Poor collateralization n = 133 | Good collateralization n = 658 | P value | |
Male, n(%) | 294 (82.8) | 1074 (82.7) | 0.974 | 174 (78.4) | 508 (79.4) | 0.753 | 120 (90.2) | 566 (86.0) | 0.192 |
Age, years | 57.7 ± 10.5 | 59.1 ± 10.3 | 0.022 | 57.2 ± 10.6 | 58.7 ± 10.2 | 0.057 | 58.6 ± 10.4 | 59.6 ± 10.3 | 0.346 |
BMI, Kg/m2 | 28.1 ± 3.7 | 26.0 ± 3.1 |  < 0.001 | 28.9 ± 4.0 | 26.9 ± 3.1 |  < 0.001 | 26.9 ± 2.8 | 25.2 ± 2.8 |  < 0.001 |
HT, n(%) | 255 (71.8) | 816 (62.9) | 0.002 | 182 (82.0) | 497 (77.7) | 0.174 | 73 (54.9) | 319 (48.5) | 0.178 |
T2DM, n(%) | 156 (43.9) | 414 (31.9) |  < 0.001 | 118 (53.2) | 285 (44.5) | 0.027 | 38 (28.6) | 129 (19.6) | 0.021 |
Renal disease, n(%) | 10 (2.8) | 25 (1.9) | 0.302 | 8 (3.6) | 13 (2.0) | 0.190 | 2 (1.5) | 12 (1.8) | 0.799 |
Metabolic syndrome, n(%) | 222 (62.5) | 640 (49.3) |  < 0.001 | – | – | – | – | – | – |
Former smoker, n(%) | 56 (15.8) | 211 (16.3) | 0.827 | 32 (14.4) | 98 (15.3) | 0.747 | 24 (18.0) | 113 (17.2) | 0.809 |
Current smoker, n(%) | 146 (41.1) | 540 (41.6) | 0.872 | 80 (36.0) | 267 (41.7) | 0.137 | 66 (49.6) | 273 (41.5) | 0.197 |
Prior MI, n(%) | 102 (28.7) | 359 (27.7) | 0.689 | 63 (28.4) | 189 (29.5) | 0.745 | 39 (29.3) | 170 (25.8) | 0.405 |
Stroke, n(%) | 20 (5.6) | 89 (6.9) | 0.411 | 14 (6.3) | 49 (7.7) | 0.505 | 6 (4.5) | 40 (6.1) | 0.481 |
History of PCI, n(%) | 103 (29.0) | 386 (29.7) | 0.791 | 69 (31.1) | 211 (33.0) | 0.605 | 34 (25.6) | 175 (26.6) | 0.806 |
SBP, mmHg | 132.6 ± 16.1 | 127.3 ± 16.1 |  < 0.001 | 135.1 ± 15.5 | 128.6 ± 16.3 |  < 0.001 | 128.3 ± 16.4 | 126.0 ± 15.7 | 0.117 |
DBP, mmHg | 79.5 ± 11.8 | 75.7 ± 10.6 |  < 0.001 | 81.0 ± 12.0 | 76.3 ± 10.6 |  < 0.001 | 77.2 ± 11.0 | 75.0 ± 10.5 | 0.033 |
HR, bpm | 71.7 ± 9.4 | 72.0 ± 10.5 | 0.558 | 71.8 ± 9.4 | 72.7 ± 10.5 | 0.309 | 71.4 ± 9.3 | 71.4 ± 10.5 | 0.967 |
FBG, mmol/L | 6.2 (5.1, 8.1) | 5.7 (5.1, 7.2) |  < 0.001 | 6.9 (5.6, 8.1) | 6.4 (5.5, 8.1) | 0.033 | 5.4 (4.9, 6.4) | 5.3 (4.9, 5.9) | 0.163 |
TG, mmol/L | 1.6 (1.2,2.4) | 1.4 (1.0,2.0) |  < 0.001 | 2.0 (1.6, 2.8) | 1.9 (1.3, 2.5) | 0.002 | 1.2 (1.1, 1.6) | 1.1 (0.9, 1.4) |  < 0.001 |
TC, mmol/L | 4.1 ± 1.3 | 3.8 ± 1.0 | 0.001 | 4.1 ± 1.5 | 3.8 ± 1.1 | 0.004 | 4.0 ± 1.0 | 3.8 ± 1.0 | 0.109 |
LDL-C, mmol/L | 2.3 ± 1.0 | 2.2 ± 0.9 | 0.189 | 2.3 ± 1.1 | 2.2 ± 0.9 | 0.319 | 2.4 ± 0.9 | 2.3 ± 0.9 | 0.257 |
HDL-C, mmol/L | 1.0 (0.8, 1.2) | 1.0 (0.9, 1.2) | 0.007 | 0.9 (0.8, 1.0) | 0.9(0.8, 1.0) | 0.545 | 1.1(0.9, 1.2) | 1.1(1.0, 1.3) | 0.489 |
WBC, 1012/L | 7.1 ± 1.8 | 7.0 ± 1.8 | 0.179 | 7.0 ± 1.8 | 7.1 ± 1.8 | 0.526 | 7.2 ± 1.8 | 6.8 ± 1.8 | 0.052 |
HGB, g/L | 144 (133,153) | 142 (132,152) | 0.149 | 143 (133, 154) | 142 (132, 152) | 0.293 | 144 (134,152) | 142 (132, 152) | 0.345 |
PLT, 109/L | 217.2 ± 54.5 | 218.4 ± 57.0 | 0.719 | 219.0 ± 54.8 | 219.4 ± 57.0 | 0.803 | 214.1 ± 54.1 | 217.4 ± 57.1 | 0.546 |
Cr, μmol/L | 78.5 ± 21.5 | 77.0 ± 33.1 | 0.418 | 79.3 ± 23.7 | 77.9 ± 31.4 | 0.562 | 77.3 ± 17.2 | 76.1 ± 34.6 | 0.712 |
UA, μmol/L | 361.2 (310.9, 418.2) | 350.7 (299.2, 419.0) | 0.186 | 364.1 (311.0, 425.3) | 363.6 (307.5, 432.7) | 0.778 | 357.5 (309.2, 410.9) | 341.1 (291.3, 406.1) | 0.072 |
eGFR, mL/(min·1.73 m2) | 92.8 ± 17.5 | 93.3 ± 17.0 | 0.657 | 92.0 ± 18.9 | 92.6 ± 17.8 | 0.676 | 94.3 ± 14.8 | 94.0 ± 16.1 | 0.834 |
HCY, μmol/L | 16.2 ± 8.9 | 16.2 ± 10.0 | 0.930 | 15.7 ± 8.1 | 15.8 ± 9.6 | 0.878 | 17.0 ± 10.1 | 16.6 ± 10.3 | 0.715 |
GA, % | 15.3 (13.8, 17.8) | 14.5 (13.3, 16.6) |  < 0.001 | 15.6 (14.0, 18.0) | 14.9 (13.4,18.3) | 0.023 | 14.7 (13.5, 16.7) | 14.2 (13.3, 15.8) | 0.039 |
LVEF, % | 56.9 ± 7.8 | 56.1 ± 7.8 | 0.134 | 57.0 ± 7.2 | 56.6 ± 7.7 | 0.513 | 56.8 ± 8.6 | 55.8 ± 7.9 | 0.212 |
LVEDd, mm | 50.6 ± 5.2 | 51.0 ± 5.2 | 0.249 | 50.1 ± 5.0 | 50.8 ± 5.2 | 0.084 | 51.5 ± 5.5 | 51.2 ± 5.2 | 0.502 |
LVEDs, mm | 35.3 ± 6.0 | 35.8 ± 5.8 | 0.164 | 35.0 ± 5.4 | 35.5 ± 5.7 | 0.254 | 35.8 ± 6.8 | 36.1 ± 5.8 | 0.644 |
Medication, n (%) | |||||||||
Antiplatelet | 355 (100) | 1298 (100) | 1 | 222 (100) | 640 (100) | 1 | 133 (100) | 658 (100) | 1 |
Statins | 355 (100) | 1298 (100) | 1 | 222 (100) | 640 (100) | 1 | 133 (100) | 658 (100) | 1 |
Diuretics | 45 (12.4) | 158 (12.2) | 0.798 | 33 (14.9) | 84 (13.1) | 0.514 | 12 (9.0) | 74 (11.2) | 0.452 |
ACE inhibitors/ARBs | 150 (42.3) | 471 (36.3) | 0.040 | 107 (48.2) | 276 (43.1) | 0.190 | 43 (32.3) | 195 (29.6) | 0.536 |
β-blockers | 236 (66.5) | 846 (65.2) | 0.648 | 148 (66.7) | 446 (69.7) | 0.402 | 88 (66.2) | 400 (60.8) | 0.245 |
CCBs | 111 (31.3) | 369 (28.4) | 0.296 | 71 (31.3) | 221 (34.6) | 0.489 | 40 (30.1) | 148 (22.5) | 0.061 |
Hypoglycaemic agents | 107 (30.1) | 320 (24.7) | 0.036 | 83 (37.4) | 216 (33.8) | 0.327 | 24 (18.0) | 104 (15.3) | 0.522 |
Target vessel, n (%) | |||||||||
RCA | 167 (47.0) | 576 (44.4) | 0.371 | 104 (46.8) | 288 (45.0) | 0.634 | 63 (47.4) | 288 (43.8) | 0.446 |
LAD | 132 (37.2) | 491 (37.8) | 0.824 | 89 (40.1) | 227 (35.5) | 0.218 | 43 (32.3) | 264 (40.1) | 0.093 |
LCX | 63 (17.7) | 240 (18.5) | 0.748 | 33 (14.9) | 130 (20.3) | 0.074 | 30 (22.6) | 110 (16.7) | 0.109 |
Elevated BMI, n (%) | 88 (24.8) | 136 (10.5) |  < 0.001 | 83 (37.4) | 117 (18.3) |  < 0.001 | 5 (3.8) | 19 (2.9) | 0.593 |
Elevated BP,n (%) | 293 (82.5) | 957 (73.7) | 0.001 | 208 (97.3) | 559 (87.3) | 0.009 | 85 (63.9) | 398 (60.5) | 0.460 |
Elevated FBG, n (%) | 238 (67.0) | 751 (57.9) | 0.002 | 181 (81.5) | 516 (80.6) | 0.767 | 57 (42.9) | 235 (35.7) | 0.119 |
Reduced HDL-C, n (%) | 247 (69.6) | 837 (64.5) | 0.073 | 195 (87.8) | 580 (90.6) | 0.235 | 52 (39.1) | 257 (39.1) | 0.993 |
Elevated TG, n (%) | 166 (46.8) | 447 (34.4) |  < 0.001 | 147 (66.2) | 376 (58.8) | 0.050 | 19 (14.3) | 71 (10.8) | 0.247 |